• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺氧诱导因子-1α通过可变剪接增强 CEACAM1 对小鼠和人类肝脏缺血的耐受。

Alternative splicing of CEACAM1 by hypoxia-inducible factor-1α enhances tolerance to hepatic ischemia in mice and humans.

机构信息

Division of Liver and Pancreas Transplantation, Dumont-UCLA Transplantation Center, Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.

Department of Anesthesiology, McGovern Medical School at UTHealth, Houston, TX 77030, USA.

出版信息

Sci Transl Med. 2023 Aug 2;15(707):eadf2059. doi: 10.1126/scitranslmed.adf2059.

DOI:10.1126/scitranslmed.adf2059
PMID:37531413
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11164245/
Abstract

Although alternative splicing (AS) drives transcriptional responses and cellular adaptation to environmental stresses, its contributions in organ transplantation have not been appreciated. We have shown that carcinoembryonic antigen-related cell adhesion molecule (Ceacam1; ), a transmembrane biliary glycoprotein expressed in epithelial, endothelial, and immune cells, determines donor liver transplant quality. Here, we studied how AS of affects ischemia-reperfusion injury (IRI) in mouse and human livers. We found that the short cytoplasmic isoform increased during early acute and late resolution phases of warm IRI injury in mice. Transfection of Ceacam1-deficient mouse hepatocytes with adenoviral Ceacam1-S mitigated hypoxia-induced loss of cellular adhesion by repressing the Ask1/p-p38 cell death pathway. Nucleic acid-blocking morpholinos, designed to selectively induce Ceacam1-S, protected hepatocyte cultures against temperature-induced stress in vitro. Luciferase and chromatin immunoprecipitation assays identified direct binding of hypoxia-inducible factor-1α (Hif-1α) to the mouse polypyrimidine tract binding protein 1 () promoter region. Dimethyloxalylglycine protected mouse livers from warm IR stress and hepatocellular damage by inhibiting prolyl hydroxylase domain-containing protein 1 and promoting AS of . Last, analysis of 46 human donor liver grafts revealed that positively correlated with pretransplant expression. This also correlated with better transplant outcomes, including reduced , total bilirubin, proinflammatory , cytokines, immune activation markers , and incidence of delayed complications from biliary anastomosis. This translational study identified mouse Hif-1α-controlled AS of , through transcriptional regulation of promoter region, as a functional underpinning of hepatoprotection against IR stress and tissue damage in liver transplantation.

摘要

虽然可变剪接(AS)驱动转录反应和细胞适应环境压力,但它在器官移植中的贡献尚未得到重视。我们已经表明,癌胚抗原相关细胞黏附分子(Ceacam1;)是一种在上皮细胞、内皮细胞和免疫细胞中表达的跨膜胆汁糖蛋白,决定了供体肝移植的质量。在这里,我们研究了 AS 对小鼠和人类肝脏缺血再灌注损伤(IRI)的影响。我们发现,在小鼠的温暖 IRI 损伤的早期急性和晚期缓解阶段,短细胞质同工型 增加。用腺病毒 Ceacam1-S 转染 Ceacam1 缺陷型小鼠肝细胞可通过抑制 Ask1/p-p38 细胞死亡途径来减轻缺氧诱导的细胞黏附丧失。为了选择性地诱导 Ceacam1-S,设计了核酸阻断型 morpholino,可保护肝细胞培养物免受体外温度应激。荧光素酶和染色质免疫沉淀实验鉴定了缺氧诱导因子-1α(Hif-1α)与小鼠多嘧啶 tract 结合蛋白 1 () 启动子区域的直接结合。二甲氧酰基甘氨酸通过抑制脯氨酰羟化酶结构域蛋白 1 并促进 AS 的发生,保护小鼠肝脏免受温暖的 IR 应激和肝细胞损伤。最后,分析了 46 例人类供体肝移植的结果表明, 与移植前的 表达呈正相关。这也与更好的移植结果相关,包括降低 、总胆红素、促炎 、细胞因子、免疫激活标志物 ,以及减少胆吻合口延迟并发症的发生率。这项转化研究鉴定了小鼠 Hif-1α 控制的 AS ,通过转录调节 启动子区域,作为肝脏移植中 IR 应激和组织损伤的肝保护的功能基础。

相似文献

1
Alternative splicing of CEACAM1 by hypoxia-inducible factor-1α enhances tolerance to hepatic ischemia in mice and humans.缺氧诱导因子-1α通过可变剪接增强 CEACAM1 对小鼠和人类肝脏缺血的耐受。
Sci Transl Med. 2023 Aug 2;15(707):eadf2059. doi: 10.1126/scitranslmed.adf2059.
2
Hepatic CEACAM1 expression indicates donor liver quality and prevents early transplantation injury.肝 CEACAM1 表达可指示供体肝质量并预防早期移植损伤。
J Clin Invest. 2020 May 1;130(5):2689-2704. doi: 10.1172/JCI133142.
3
Spliced CEACAM1: A Potential Novel Biomarker and Target for Ameliorating Liver Ischemia-reperfusion Injury.拼接型 CEACAM1:一种潜在的新型生物标志物和靶标,可改善肝缺血再灌注损伤。
Transplantation. 2024 Mar 1;108(3):585-587. doi: 10.1097/TP.0000000000004886. Epub 2024 Feb 21.
4
Neutrophil CEACAM1 determines susceptibility to NETosis by regulating the S1PR2/S1PR3 axis in liver transplantation.中性粒细胞 CEACAM1 通过调节肝移植中的 S1PR2/S1PR3 轴决定 NETosis 的易感性。
J Clin Invest. 2023 Feb 1;133(3):e162940. doi: 10.1172/JCI162940.
5
KEAP1-NRF2 complex in ischemia-induced hepatocellular damage of mouse liver transplants.KEAP1-NRF2复合物在小鼠肝移植缺血诱导的肝细胞损伤中的作用
J Hepatol. 2013 Dec;59(6):1200-7. doi: 10.1016/j.jhep.2013.07.016. Epub 2013 Jul 16.
6
Hypoxia-inducible factor-1alpha protects the liver against ischemia-reperfusion injury by regulating the A2B adenosine receptor.缺氧诱导因子-1α通过调节A2B腺苷受体保护肝脏免受缺血再灌注损伤。
Bioengineered. 2021 Dec;12(1):3737-3752. doi: 10.1080/21655979.2021.1953217.
7
Activation of YAP attenuates hepatic damage and fibrosis in liver ischemia-reperfusion injury.YAP 的激活可减轻肝缺血再灌注损伤中的肝损伤和纤维化。
J Hepatol. 2019 Oct;71(4):719-730. doi: 10.1016/j.jhep.2019.05.029. Epub 2019 Jun 13.
8
Hypoxia inducible factor 1α promotes interleukin-1 receptor antagonist expression during hepatic ischemia-reperfusion injury.缺氧诱导因子 1α 在肝缺血再灌注损伤中促进白细胞介素-1 受体拮抗剂的表达。
World J Gastroenterol. 2022 Oct 14;28(38):5573-5588. doi: 10.3748/wjg.v28.i38.5573.
9
A Soluble Form of P Selectin Glycoprotein Ligand 1 Requires Signaling by Nuclear Factor Erythroid 2-Related Factor 2 to Protect Liver Transplant Endothelial Cells Against Ischemia-Reperfusion Injury.可溶性P选择素糖蛋白配体1的一种形式需要红系2相关因子2信号传导来保护肝移植内皮细胞免受缺血再灌注损伤。
Am J Transplant. 2017 Jun;17(6):1462-1475. doi: 10.1111/ajt.14159. Epub 2017 Feb 6.
10
Hypoxia-inducible factor-1α-dependent induction of miR122 enhances hepatic ischemia tolerance.缺氧诱导因子-1α 依赖性诱导 miR122 增强肝缺血耐受。
J Clin Invest. 2021 Apr 1;131(7). doi: 10.1172/JCI140300.

引用本文的文献

1
Feedback Loops Shape Oxidative and Immune Interactions in Hepatic Ischemia-Reperfusion Injury.反馈回路塑造肝脏缺血再灌注损伤中的氧化与免疫相互作用。
Antioxidants (Basel). 2025 Jul 31;14(8):944. doi: 10.3390/antiox14080944.
2
Direct RNA sequencing reveals chicken post-transcriptional modifications in response to Campylobacter jejuni inoculation.直接RNA测序揭示了鸡对空肠弯曲菌接种的转录后修饰反应。
BMC Genomics. 2025 Apr 14;26(1):374. doi: 10.1186/s12864-025-11564-3.
3
Comprehensive analysis of immunogenic cell death-related genes in liver ischemia-reperfusion injury.肝脏缺血再灌注损伤中免疫原性细胞死亡相关基因的综合分析
Front Immunol. 2025 Feb 17;16:1545185. doi: 10.3389/fimmu.2025.1545185. eCollection 2025.
4
Genome-wide analysis of alternative splicing differences in hepatic ischemia reperfusion injury.肝缺血再灌注损伤中可变剪接差异的全基因组分析。
Sci Rep. 2024 Dec 28;14(1):31349. doi: 10.1038/s41598-024-82846-1.
5
Mechanism and function of CEACAM1 splice isoforms.癌胚抗原相关细胞黏附分子1(CEACAM1)剪接异构体的机制与功能
Eur J Clin Invest. 2024 Dec;54 Suppl 2(Suppl 2):e14350. doi: 10.1111/eci.14350.
6
Current investigation of carcinoembryonic antigen cell adhesion molecule (CEACAM) biology summary of the 32nd CEA symposium: 20-23 September 2024. Würzburg, Germany.癌胚抗原细胞粘附分子(CEACAM)生物学的当前研究——第32届癌胚抗原研讨会综述:2024年9月20日至23日,德国维尔茨堡
Eur J Clin Invest. 2024 Dec;54 Suppl 2(Suppl 2):e14355. doi: 10.1111/eci.14355.
7
Current status and perspective on molecular targets and therapeutic intervention strategy in hepatic ischemia-reperfusion injury.肝缺血再灌注损伤中分子靶点及治疗干预策略的现状和展望。
Clin Mol Hepatol. 2024 Oct;30(4):585-619. doi: 10.3350/cmh.2024.0222. Epub 2024 Jul 1.
8
The Coming Age of Antisense Oligos for the Treatment of Hepatic Ischemia/Reperfusion (IRI) and Other Liver Disorders: Role of Oxidative Stress and Potential Antioxidant Effect.反义寡核苷酸治疗肝缺血/再灌注损伤(IRI)及其他肝脏疾病的新时代来临:氧化应激的作用及潜在抗氧化效应
Antioxidants (Basel). 2024 May 31;13(6):678. doi: 10.3390/antiox13060678.
9
Steatotic Donor Transplant Livers: Preservation Strategies to Mitigate against Ischaemia-Reperfusion Injury.脂肪变性供体肝移植:减轻缺血再灌注损伤的保护策略。
Int J Mol Sci. 2024 Apr 24;25(9):4648. doi: 10.3390/ijms25094648.
10
Chromatin target of protein arginine methyltransferases alleviates cerebral ischemia/reperfusion-induced injury by regulating RNA alternative splicing.蛋白质精氨酸甲基转移酶的染色质靶点通过调节RNA可变剪接减轻脑缺血/再灌注诱导的损伤。
iScience. 2023 Dec 7;27(1):108688. doi: 10.1016/j.isci.2023.108688. eCollection 2024 Jan 19.

本文引用的文献

1
Neutrophil CEACAM1 determines susceptibility to NETosis by regulating the S1PR2/S1PR3 axis in liver transplantation.中性粒细胞 CEACAM1 通过调节肝移植中的 S1PR2/S1PR3 轴决定 NETosis 的易感性。
J Clin Invest. 2023 Feb 1;133(3):e162940. doi: 10.1172/JCI162940.
2
Myeloid Ikaros-SIRT1 signaling axis regulates hepatic inflammation and pyroptosis in ischemia-stressed mouse and human liver.髓样 Ikaros-SIRT1 信号轴调节缺血应激小鼠和人肝中的肝脏炎症和细胞焦亡。
J Hepatol. 2022 Apr;76(4):896-909. doi: 10.1016/j.jhep.2021.11.026. Epub 2021 Dec 3.
3
Serum Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 Level in Patients with Hepatocellular Carcinoma.血清癌胚抗原相关细胞黏附分子 1 水平与肝细胞癌。
Asian Pac J Cancer Prev. 2021 Nov 1;22(11):3521-3524. doi: 10.31557/APJCP.2021.22.11.3521.
4
Ischemic heart injury leads to HIF1-dependent differential splicing of CaMK2γ.缺血性心脏损伤导致 HIF1 依赖性 CaMK2γ 的差异剪接。
Sci Rep. 2021 Jun 23;11(1):13116. doi: 10.1038/s41598-021-92426-2.
5
HIF-1α and HIF-2α redundantly promote retinal neovascularization in patients with ischemic retinal disease.缺氧诱导因子-1α(HIF-1α)和缺氧诱导因子-2α(HIF-2α)在缺血性视网膜疾病患者中冗余性促进视网膜新生血管形成。
J Clin Invest. 2021 Jun 15;131(12). doi: 10.1172/JCI139202.
6
HIF-1α is a negative regulator of interferon regulatory factors: Implications for interferon production by hypoxic monocytes.低氧诱导因子 1α 是干扰素调节因子的负调控因子:对低氧单核细胞产生干扰素的影响。
Proc Natl Acad Sci U S A. 2021 Jun 29;118(26). doi: 10.1073/pnas.2106017118.
7
PTBP1 Targets ILK to Regulate the Hypoxia-Induced Phenotypic Transformation of Pulmonary Artery Smooth Muscle Cells.PTBP1 通过靶向 ILK 调节肺动脉平滑肌细胞缺氧诱导的表型转化。
Drug Des Devel Ther. 2021 May 13;15:2025-2033. doi: 10.2147/DDDT.S275000. eCollection 2021.
8
Co-administration of lipopolysaccharide and D-galactosamine induces genotoxicity in mouse liver.脂多糖和半乳糖胺联合给药诱导小鼠肝损伤。
Sci Rep. 2021 Jan 18;11(1):1733. doi: 10.1038/s41598-021-81383-5.
9
CEACAM1 Inhibited IκB-α/NF-κB Signal Pathway Via Targeting MMP-9/TIMP-1 Axis in Diabetic Atherosclerosis.CEACAM1 通过靶向 MMP-9/TIMP-1 轴抑制糖尿病动脉粥样硬化中的 IκB-α/NF-κB 信号通路。
J Cardiovasc Pharmacol. 2020 Sep;76(3):329-336. doi: 10.1097/FJC.0000000000000868.
10
Hypoxia-induced alternative splicing: the 11th Hallmark of Cancer.缺氧诱导的选择性剪接:癌症的第 11 个特征。
J Exp Clin Cancer Res. 2020 Jun 15;39(1):110. doi: 10.1186/s13046-020-01616-9.